Strategic Partnerships Target Integral BioSystems as a preferred CRO partner for complex formulation development and scale-up projects in ophthalmics, dermals, injectables, and niche delivery routes, leveraging their licensable technologies and global slide into clinic-ready products.

ARVO Participation Capitalize on their active presence at ARVO conferences to propose collaboration on nano-delivery platforms like NanoM-Wafer and to offer joint data generation, validation studies, or co-presentation opportunities that raise joint visibility.

AI Information Page Position AI-assisted discovery and data handling services to support their AI information page; offer structured data integration, AI-driven project scoping, and automated literature/competitor benchmarking to enhance decision making and capability storytelling.

Scale-Up Expertise Pitch outsourced manufacturing enablement and technology transfer services to accelerate transition from R&D to production for complex formulations, with a focus on their 10,000 sq ft facility capacity and potential for scalable pilot runs.

Financial Fit Propose tiered engagement pricing and risk-sharing models aligned with their mid-market revenue range (1–10 million) to win multi-project contracts, including long-term development programs and repeatable formula development pipelines.